Stamp T C, Doar J W, Wynn V
J Clin Pathol. 1969 Mar;22(2):132-5. doi: 10.1136/jcp.22.2.132.
Fasting serum lipid levels and changes in plasma glucose, fatty acid non-esterified (Nefa), and blood pyruvate levels during intravenous glucose tolerance tests were measured in 13 normal subjects before and one, five, and 15 days after the administration of 1-triiodothyronine (T3) calculated as 6 mug/kg body weight. Significant increases in the mean basal metabolic rate and the mean fasting plasma Nefa level occurred within 10 to 17 hours of a single dose of T3, while a rise in the mean fasting plasma glucose concentration just failed to achieve significance. Fasting concentrations of blood pyruvate and serum triglyceride were unaffected. A significant fall in serum cholesterol levels was produced and lasted at least five days. All other indices returned to normal by five days.During intravenous glucose tolerance tests performed at intervals after T3 administration no change in plasma glucose levels from control values was seen. Mean plasma Nefa and blood pyruvate levels, however, were significantly raised above control values during the early stages of the test 10 to 17 hours after T3. The relationship between these findings and those observed in clinical thyrotoxicosis is discussed.
对13名正常受试者在静脉注射按6微克/千克体重计算的1-三碘甲状腺原氨酸(T3)之前以及给药后1天、5天和15天,测定了空腹血脂水平以及静脉葡萄糖耐量试验期间血浆葡萄糖、非酯化脂肪酸(Nefa)和血液丙酮酸水平的变化。单次服用T3后10至17小时内,平均基础代谢率和平均空腹血浆Nefa水平显著升高,而平均空腹血浆葡萄糖浓度的升高刚刚未达到显著水平。空腹血液丙酮酸和血清甘油三酯浓度未受影响。血清胆固醇水平显著下降且至少持续了5天。所有其他指标在5天时恢复正常。在T3给药后定期进行静脉葡萄糖耐量试验期间,未观察到血浆葡萄糖水平与对照值有变化。然而,在T3给药后10至17小时的试验早期,平均血浆Nefa和血液丙酮酸水平显著高于对照值。讨论了这些发现与临床甲状腺毒症中观察到的现象之间的关系。